Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer Says 'Not Now' To Monsanto Spin-Off Amid Ongoing Roundup Legal Battle
04:32am, Wednesday, 03'rd Jun 2026
Bayer rules out a Monsanto spin-off despite mounting Roundup lawsuits that continue to pressure the company.
Bayer says no plans to restructure despite litigation threat
07:11pm, Tuesday, 02'nd Jun 2026
Bayer has no plans to spin off Monsanto, a representative said on Tuesday, even as the company faces an avalanche of lawsuits over its Roundup weedkiller.
WHIPPANY, N.J.--(BUSINESS WIRE)--Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with
Bayer sued for allegedly monopolizing US market for GMO corn seeds
05:54pm, Wednesday, 27'th May 2026
Bayer used illegal and anti-competitive practices to monopolize the U.S. market for genetically engineered corn seeds, reaping "hundreds of millions, if not billions, of ill-gotten dollars," accord
4 Large-Cap Pharma Stocks to Buy as Industry Recovery Accelerates
09:51am, Tuesday, 26'th May 2026
In the Large-Cap Pharmaceuticals industry, LLY, J&J, NVO and BAYRY are worth retaining as the industry shows some recovery.
BAYRY's Kerendia Label Expansion Application Gets Priority Review
02:00pm, Thursday, 21'st May 2026
Bayer wins FDA Priority Review for Kerendia label expansion in CKD tied to type I diabetes after strong phase III data.
Bayer says FDA grants priority review designation for finerenone
02:56am, Thursday, 21'st May 2026
Bayer said on Thursday that the U.S. Food and Drug Administration had accepted its supplemental New Drug Application for finerenone and granted priority review designation.
BAYRY or RHHBY: Which Is the Better Value Stock Right Now?
12:40pm, Wednesday, 20'th May 2026
Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Bayer Aktiengesellschaft (BAYRY) and Roche Holding AG (RHHBY). But which of these two companies is the best option for
FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC
12:06pm, Tuesday, 19'th May 2026
BAYRY wins FDA priority review for sevabertinib in first-line HER2-mutant NSCLC, building momentum for the oral TKI.
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
11:30am, Tuesday, 19'th May 2026
BAYRY gains FDA Priority Review for asundexian NDA after phase III data showed a 26% cut in ischemic stroke risk without more major bleeding.
Bayer agrees to pay $133 million for PCB cleanup in two states
03:39pm, Monday, 18'th May 2026
Bayer's Monsanto unit on Monday said it would pay at least $133 million to settle Michigan and Rhode Island's claims that the company contaminated the states' natural resources with toxic chemic
Bayer Aktiengesellschaft Backs Crop Science Targets as Seed Pipeline Gains Momentum
12:16pm, Thursday, 14'th May 2026
Bayer Aktiengesellschaft ETR: BAYN executives said the company's Crop Science division remains on track with a five-year plan centered on cost savings, margin expansion and a slate of product launches
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer and country superstar and five-time Entertainer of the Year Luke Bryan today launched their 2026 campaign to expand access to food and nutrition in rural America
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts Sales
12:26pm, Tuesday, 12'th May 2026
BAYRY beats Q1 earnings estimates as Crop Science sales rise, while Nubeqa and Kerendia gains help offset declines in Xarelto and Eylea.
Bayer Aktiengesellschaft (BAYRY) Q1 2026 Earnings Call Transcript
08:00am, Tuesday, 12'th May 2026
Bayer Aktiengesellschaft (BAYRY) Q1 2026 Earnings Call Transcript
